查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1835214

基因检测市场按产品类型、技术、应用、分销管道和最终用户划分－2025-2032 年全球预测

Genetic Testing Market by Product, Test Type, Technology, Application, Distribution Channel, End-User - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2032 年，基因检测市场规模将成长至 397.2 亿美元，复合年增长率为 14.38%。

主要市场统计数据
基准年2024年 135.5亿美元
预计2025年 154.4亿美元
预测年份：2032年 397.2亿美元
复合年增长率（%） 14.38%

广泛采用基因检测生态系统，扩充性

受分子技术进步、临床应用拓展以及消费者对个人化医疗日益增长的兴趣的推动，基因检测领域正经历快速发展。诊断实验室、医院和直销管道正在将先进的检测方法整合到其工作流程中，而软体和服务也日益支持解读、报告和纵向资料管理。这些趋势的融合正在再形成医疗服务提供者、支付方和患者与基因资讯的互动方式。

此外，监管机构和专业协会正在明确分析效度、临床效用和资料隐私的标准，从而影响临床和消费者环境中的采用模式。在实验室平衡吞吐量、品管和供应链扩充性的过程中，营运可扩展性仍然是平行的优先事项。当相关人员应对这些动态，关于技术平台、测试组合和分销模式的策略选择将决定他们的竞争地位和获取临床价值的能力。因此，相关人员应优先考虑严格的检验、清晰的临床路径以及支援与电子健康记录和基于价值的护理计划整合的可互通的数据基础。

整合实验室平台、云端原生解释、不断发展的交付模式以及加强的法律规范推动了遗传学的转型

基因检测领域正从孤立的检测方法转向整合的数据主导产品，这些产品将实验室能力与解读软体和持续的临床决策支援相结合。基因表现定序和微阵列工具补充了定序和PCR平台，而云端生物资讯学正在加速研究週转并增强变异解读。这些技术的融合使得更全面的诊断组合成为可能，并促进了整个临床路径的多模态检测策略。

与此同时，市场相关人员正在重新思考交付模式。诊断实验室和医院正在优化内部检测以满足紧急需求，而外包合作伙伴和软体供应商则提供专业服务和分析。直接面向消费者的管道不断提升人们对基因健康的认识，促使临床医生和付款人完善效用框架。监管和报销趋势正在推动标准化报告和证据创建，从而支持更广泛的临床应用。最终，最具变革性的转变将是平衡技术创新与检验的临床效用、强大的资料管治和永续的营运模式。

评估 2025 年关税如何再形成基因检测相关人员的采购、供应链和营运弹性

2025年美国加征关税，为整个基因检测生态系统的采购、供应链策略和成本管理带来了新的变数。这迫使仪器和耗材製造商重新评估筹资策略，并促使实验室评估进口试剂和设备的总到岸成本。为此，相关人员正在重新分配采购量，增加供应商多元化，并探索本地製造方案，以降低关税相关价格波动带来的风险。

这些调整正在层层递进地影响营运计画。一些实验室正在延长库存补货週期，并收紧供应商合同，以应对潜在的关税延迟。另一些实验室则正在加快检验依赖不同组件组合或国内供应链的替代平台。同时，供应商和检测机构之间正在建立策略联盟，共用担风险、共同开发在地化供应解决方案，并提供配套服务协议，从而降低贸易脆弱性。展望未来，关税相关的压力可能会强化供应链透明度、双重采购以及优先考虑临床检测服务连续性的客户-供应商伙伴关係关係的价值。

透过全面的细分洞察，协调跨技术、产品类型、应用、通路和最终用户的产品开发、商业化和营运优先级

详细了解市场区隔对于制定产品策略和确定投资优先顺序至关重要。从产品类型的角度来看，相关人员必须区分驱动经常性收益和资本支出週期的消耗品和设备，以及透过分析、报告和工作流程整合建立长期客户关係的软体和服务。每个产品类型都有不同的上市要求和服务架构。

考虑到检测类型的细分，支付方的接受度和临床工作流程在带因者检测、诊断性检测、新生儿筛检、药物基因组学、胚胎着床前检测、产前检测、症状前检测和预测性检测之间差异显着。因此，产品开发应与每种检测类型的实证基础和监管预期保持一致。从技术角度来看，细胞遗传学、DNA序列测定、基因表现分析、微阵列和PCR之间的选择会影响检测灵敏度、通量和每次检测的成本，并且必须与预期的临床和消费者用途保持一致。

应用导向的细分揭示了自体免疫疾病、癌症、慢性病、遗传性疾病和神经退化性疾病的不同需求动态，每种疾病都需要不同的检验资料集和临床决策框架。分销管道（线下和线上模式）的差异决定了检测的销售、知情同意和交付方式，而终端用户细分（诊断实验室、家庭环境、医院/诊所）则决定了服务等级要求、整合需求和培训义务。这些细分观点提供了蓝图，用于将研发、商业和营运重点与实际应用路径结合。

美洲、欧洲、中东和非洲以及亚太市场的监管细微差别、采用速度和供应链本地化的区域观点

区域动态持续对采用曲线、监管预期和伙伴关係策略产生重大影响。在美洲，临床整合和消费者意识的提升正在推动对多样化检测组合的需求，相关人员也受益于成熟的报销途径和支持创新诊断试验的密集临床网络。随着整合照护模式的转变，医疗保健机构越来越多地将基因组学洞察纳入慢性病管理和肿瘤学途径，从而推动对本地实验室能力和解读服务的投资。

在欧洲、中东和非洲，法律规范和医疗基础设施的差异带来了多样化的机会。一些国家强调集中式新生儿筛检和国家倡议计划，而其他国家则拓展私人实验室服务。这种多样性需要製定适应性强的打入市场策略，以因应不同的认证要求和资料保护规范。同时，在亚太地区，快速的技术应用和不断扩展的临床检测能力正在支持医院检测和麵向消费者的服务的成长。区域供应链和製造地也日趋成熟，为在地化生产和减少对跨境物流的依赖提供了机会。总而言之，这些区域特征需要量身定制的商业模式、监管参与和社区为基础的伙伴关係，以实现永续的采用。

主要企业动态透过平台整合、伙伴关係、资料互通性和卓越营运凸显策略差异化

基因检测领域的竞争态势由成熟的设备製造商、专业的检测试剂开发商、生物资讯学提供者以及全方位服务的实验室所构成。领先的公司透过平台广度、解读演算法、变异管理、真实世界证据产生、临床医生教育和其他附加价值服务来脱颖而出。随着互通性和数据标准变得越来越重要，投资强大的 API 和 EHR 整合的公司将在临床领域获得竞争优势。

策略方法多种多样，有些优先考虑垂直整合，将仪器、耗材和专有检测手段结合起来，以获取整个价值链的利润；而另一些则侧重于伙伴关係和开放平台策略，透过第三方检验加速应用。此外，与医院系统、学术中心和付款方建立联盟有助于证据开发，并有助于确保覆盖途径。最后，卓越的营运（透过一致的品质指标、可扩展的物流和响应迅速的客户支援来体现）仍然是实验室和医疗系统在选择供应商合作伙伴时的决定性因素。

为高阶主管提供可行的建议，以建立平台灵活性、供应链弹性、资料互通性、监管参与和临床服务连续性

产业领导者应采取多管齐下的方法，确保基因检测的长期相关性和影响力。首先，优先投资模组化平台，以便快速部署新的检测方法并实现灵活的服务层级。其次，将供应商多元化和区域采购制度化，以减少关税和物流中断，同时确保品质和验证时限。

第三，我们将透过实施标准化报告格式、API驱动的电子健康记录整合以及可由外部相关人员审核的透明变数解释框架，来增强资料管理和互通性。第四，我们将积极与监管机构、付款方和专业协会合作，共同製定能够证明临床效用并为覆盖政策提供资讯的证据产生策略。第五，我们将扩展服务范围，超越即时检测，涵盖纵向病患监测、临床医生决策支援和精选资料库，以创造经常性收益并加强客户关係。这些措施将使公司能够充分利用临床需求，同时管理营运风险和监管复杂性。

结合相关人员访谈、文献综合、三角测量和专家同行评审的稳健混合调查方法，以确保可操作且有效的见解

本分析背后的调查方法结合了定性和定量分析，旨在产生可操作且可复製的洞察。主要研究包括对实验室主任、医院采购主管、临床遗传学家和公司高管的结构化访谈，以了解他们对技术选择、报销挑战和业务重点的第一手观点。次要研究涵盖同行评审文献、技术白皮书、监管指南文件和公开的企业资料，旨在将主要研究的结果与实际情况联繫起来，并确保其与现行标准保持一致。

数据合成利用三角测量技术来协调相关人员观点的差异，并根据已记录的实践模式检验主题研究结果。测试方法强调透明度，将测试方法与临床路径进行映射，并透过相关人员访谈对细分方案进行最后覆核，以确认其实际相关性。在适用的情况下，进行了敏感性检验，以检验结论在不同操作场景下的稳健性。最后，由具有临床和实验室教学经验的专家对研究结果进行同行评审，以确认其准确性和实际适用性。

结论整合了负责任的采用、操作严谨性、监管参与和伙伴关係主导的基因检测成长的策略要务

摘要：基因检测领域正曲折点，技术成熟度、监管复杂性和不断发展的医疗模式交织在一起，创造了重大的策略机会。将产品开发与有效的临床效用相结合、投资于可互通的数据基础设施并增强供应链弹性的开发，将最有可能实现长期价值。同时，积极主动的监管参与和严格的证据生成对于扩大临床应用和确保永续的报销途径仍然至关重要。

成功的参与者将能够平衡创新与营运严谨性，促进临床和商业相关人员之间的伙伴关係，并设计出能够无缝融入现有医疗保健工作流程的服务。透过关注这些优先事项，市场参与企业可以加速负责任地采用基因检测技术，改善患者治疗效果，并建立能够抵御监管和宏观经济逆境的弹性经营模式。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 将人工智慧扩展到基因组数据解释工作流程
  • 消费者基因检测套组的普及及其法律规范挑战
  • 基于 CRISPR 的基因编辑技术的进步使得精准标靶化遗传疾病成为可能
  • 扩展药物基因组学，根据患者基因图谱进行个人化药物选择
  • 家用样本采集套件改善了农村地区获得基因检测服务的机会
  • 生物技术公司与医疗保健提供者建立策略伙伴关係，扩大基因检测项目
  • 对整合基因组学、蛋白质组学和代谢体学数据的综合多体学方法的需求日益增长
  • 创投的增加推动了创业投资检测领域的创新和Start-Ups的成长
  • 不断变化的法规结构和资料隐私要求将影响基因检测商业化策略
  • 随着越来越多的孕妇寻求早期发现遗传健康风险，产前基因检测激增

第六章：2025年美国关税的累积影响

第七章：人工智慧的累积影响，2025年

第八章 基因检测市场（按产品）

  • 耗材和设备
  • 软体和服务

第九章 基因检测市场（依检测类型）

  • 职业测试
  • 诊断测试
  • 新生儿筛检
  • 药物基因组学
  • 胚胎着床前测试
  • 产前检查
  • 症状前和预测性检测

第十章 基因检测市场（按技术）

  • 细胞遗传学
  • DNA序列分析
  • 基因表现
  • 微阵列
  • PCR

第十一章 基因检测市场（按应用）

  • 自体免疫疾病
  • 癌症
  • 慢性病
  • 遗传性疾病
  • 神经退化性疾病

第十二章 基因检测市场（按分销管道）

  • 离线
  • 在线的

第十三章 基因检测市场（依最终用户划分）

  • 诊断实验室
  • 主页设定
  • 医院和诊所

第十四章 基因检测市场（按地区）

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 基因检测市场（依类别）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国基因检测市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Abbott Laboratories
    • Agilent Technologies, Inc.
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • Bio-Techne Corporation
    • Bruker Corporation
    • Centogene NV
    • Color Health, Inc.
    • CooperSurgical Inc.
    • Editas Medicine, Inc.
    • Eugene Labs Pty Ltd.
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche AG
    • Fulgent Genetics, Inc.
    • Gene by Gene, Ltd.
    • GeneDx, LLC
    • Illumina, Inc.
    • Invitae Corporation
    • Laboratory Corporation of America Holdings
    • Living DNA Ltd.
    • Macrogen, Inc.
    • MyHeritage Ltd.
    • Myriad Genetics, Inc.
    • Natera, Inc.
    • Newtopia Inc.
    • PathogenDx Corporation
    • PerkinElmer Inc.
    • Qiagen NV
    • Quest Diagnostics Incorporated
    • Sanofi SA
    • Thermo Fisher Scientific Inc.
Product Code: MRR-437E9896A512

The Genetic Testing Market is projected to grow by USD 39.72 billion at a CAGR of 14.38% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 13.55 billion
Estimated Year [2025] USD 15.44 billion
Forecast Year [2032] USD 39.72 billion
CAGR (%) 14.38%

An expansive introduction to the genetic testing ecosystem emphasizing clinical integration, consumer engagement, regulatory evolution, and operational scalability

The genetic testing landscape is undergoing a period of rapid refinement driven by advances in molecular technologies, expanded clinical applications, and heightened consumer interest in personalized health. Diagnostic laboratories, hospitals, and direct-to-consumer channels are integrating sophisticated assays into workflows, while software and services increasingly enable interpretation, reporting, and longitudinal data management. These converging trends are reshaping how providers, payers, and patients interact with genetic information.

Moreover, regulatory agencies and professional societies are clarifying standards for analytic validity, clinical utility, and data privacy, which in turn influence adoption patterns across clinical and consumer settings. Operational scalability remains a parallel priority as laboratories balance throughput, quality control, and supply chain resilience. As stakeholders navigate these dynamics, strategic choices around technology platforms, test portfolios, and distribution models will determine competitive positioning and the ability to capture clinical value. Consequently, stakeholders should prioritize rigorous validation, clear clinical pathways, and interoperable data infrastructures that support integration with electronic health records and value-based care initiatives.

Transformative shifts in genetics driven by integrated laboratory platforms, cloud-native interpretation, evolving delivery models, and strengthened regulatory frameworks

The landscape of genetic testing is shifting from siloed assays toward integrated, data-driven offerings that combine laboratory capabilities with interpretive software and ongoing clinical decision support. Sequencing and PCR-based platforms are being complemented by gene expression and microarray tools, while cloud-enabled bioinformatics is accelerating turnaround and enhancing variant interpretation. These technological convergences enable more comprehensive diagnostic panels and foster multi-modal testing strategies across clinical pathways.

Concurrently, market actors are rethinking delivery models. Diagnostic laboratories and hospitals are optimizing in-house testing for high-acuity needs, while outsourced partners and software vendors provide specialized services and analytics. Direct-to-consumer access continues to expand awareness of genetic health, prompting clinicians and payers to refine utility frameworks. Regulatory and reimbursement trends are encouraging standardized reporting and evidence generation, which in turn support broader clinical adoption. Ultimately, the most transformative shifts balance technological innovation with validated clinical utility, robust data governance, and sustainable operational models.

Assessment of how the 2025 tariff measures have reshaped procurement, supply chains, and operational resilience for genetic testing stakeholders

The imposition of tariffs by the United States in 2025 has introduced new variables into procurement, supply chain strategy, and cost management across the genetic testing ecosystem. Manufacturers of instruments and consumables have had to reassess sourcing strategies, and laboratories have been prompted to evaluate the total landed cost of imported reagents and equipment. In response, stakeholders are reallocating purchasing volumes, intensifying supplier diversification, and seeking regional manufacturing options to mitigate exposure to tariff-related price fluctuations.

These adjustments are cascading through operational planning. Some laboratories are lengthening inventory reorder cycles and strengthening supplier contracts to buffer against potential customs delays. Others are accelerating validation of alternative platforms that rely on different component mixes or domestic supply chains. At the same time, strategic collaborations between vendors and laboratories are being used to share risk, co-develop localized supply solutions, and provide bundled service agreements that reduce transactional vulnerabilities. Looking ahead, tariff-related pressures are likely to reinforce the value of supply chain transparency, dual-sourcing, and client-vendor partnerships that prioritize continuity of clinical testing services.

Comprehensive segmentation insights to align product development, commercialization, and operational priorities across technologies, test types, applications, channels, and end users

A granular understanding of market segmentation is essential for designing product strategies and prioritizing investments. When viewed through the lens of product categories, stakeholders must differentiate between consumables and equipment, which drive recurring revenue and capital expenditure cycles, and software and services, which create long-term client relationships through analytics, reporting, and workflow integration. Each product category imposes different go-to-market requirements and service architectures.

Considering test type segmentation, payer acceptance and clinical workflows vary significantly across carrier testing, diagnostic testing, newborn screening, pharmacogenomics, preimplantation testing, prenatal testing, and presymptomatic and predictive testing. Consequently, product development should be tailored to the unique evidentiary and regulatory expectations of each test type. From a technology standpoint, choices among cytogenetics, DNA sequencing, gene expression profiling, microarrays, and PCR influence assay sensitivity, throughput, and cost-per-test, and should align with intended clinical or consumer applications.

Application-oriented segmentation reveals differing demand dynamics across autoimmune disorders, cancer, chronic diseases, genetic disorders, and neurodegenerative diseases, each requiring distinct validation datasets and clinical decision frameworks. Distribution channel distinctions between offline and online models determine how tests are marketed, consented, and delivered, while end-user segmentation-diagnostic laboratories, home setting, and hospitals and clinics-shapes service level requirements, integration needs, and training obligations. Together, these segment perspectives provide a roadmap for aligning R&D, commercial, and operational priorities to real-world pathways of adoption.

Regional perspectives on regulatory nuance, adoption velocity, and supply chain localization across the Americas, Europe Middle East Africa, and Asia-Pacific markets

Regional dynamics continue to exert strong influence on adoption curves, regulatory expectations, and partnership strategies. In the Americas, clinical integration and consumer awareness are both driving demand for diverse testing portfolios, and stakeholders benefit from established reimbursement pathways and dense clinical networks that support trialing innovative diagnostics. Transitioning toward integrated care models, institutions are increasingly incorporating genomic insights into chronic disease management and oncology pathways, which in turn encourages investment in local laboratory capabilities and interpretive services.

Across Europe, the Middle East, and Africa, heterogeneity in regulatory frameworks and healthcare infrastructure yields a mosaic of opportunities. Some jurisdictions emphasize centralized newborn screening and national genomic initiatives, while others are scaling private laboratory services. This variability requires adaptive market entry strategies that accommodate differing certification requirements and data protection norms. Meanwhile, in the Asia-Pacific region, rapid technology adoption and expanding clinical laboratory capacity are supporting growth in both hospital-based testing and consumer-facing services. Regional supply chains and manufacturing hubs are also maturing, offering opportunities to localize production and reduce dependence on cross-border logistics. Taken together, these regional characteristics necessitate tailored commercial models, regulatory engagement, and localized partnerships to achieve sustainable adoption.

Key company dynamics revealing strategic differentiation through platform integration, partnerships, data interoperability, and operational excellence

Competitive dynamics in genetic testing are shaped by a mix of incumbent instrument manufacturers, specialized assay developers, bioinformatics providers, and integrated service laboratories. Leading actors are differentiating through platform breadth, interpretive algorithms, and value-added services such as variant curation, real-world evidence generation, and clinician education. As interoperability and data standards become more critical, companies that invest in robust APIs and EHR integration gain a competitive edge in clinical settings.

Strategic approaches also vary: some firms prioritize vertical integration by combining instrumentation, consumables, and proprietary assays to capture margin across the value chain, while others focus on partnerships and open-platform strategies that accelerate adoption through third-party validations. In addition, alliance-building with hospital systems, academic centers, and payers supports evidence development and aids in securing coverage pathways. Finally, operational excellence-demonstrated through consistent quality metrics, scalable logistics, and responsive customer support-remains a decisive factor for laboratories and health systems when selecting vendor partners.

Actionable recommendations for executives to build platform flexibility, supply chain resilience, data interoperability, regulatory engagement, and recurring clinical services

Industry leaders should adopt a multi-pronged approach to secure long-term relevance and influence in genetic testing. First, prioritize investments in modular platforms that allow rapid adoption of new assays and enable flexible service tiers; this reduces time-to-market for emerging clinical applications and supports scalability across diverse client types. Second, institutionalize supplier diversification and regional sourcing to mitigate tariff and logistics disruptions while preserving quality and validation timelines.

Third, elevate data stewardship and interoperability by implementing standardized reporting formats, API-driven integrations with electronic health records, and transparent variant interpretation frameworks that can be audited by external stakeholders. Fourth, engage proactively with regulators, payers, and professional societies to co-develop evidence generation strategies that demonstrate clinical utility and inform coverage policies. Fifth, expand service offerings beyond raw testing to include longitudinal patient monitoring, clinician decision support, and curated databases that create recurring revenue and strengthen client relationships. Together, these actions will position organizations to capitalize on clinical demand while managing operational risk and regulatory complexity.

Robust mixed-methods research methodology combining stakeholder interviews, literature synthesis, triangulation, and expert peer review to ensure practical and validated insights

The research methodology underpinning this analysis combined qualitative and quantitative approaches to produce actionable, reproducible insights. Primary research included structured interviews with laboratory directors, hospital procurement leads, clinical geneticists, and commercial executives to surface first-hand perspectives on technology choice, reimbursement challenges, and operational priorities. Secondary research encompassed peer-reviewed literature, technical white papers, regulatory guidance documents, and publicly available corporate disclosures to contextualize primary findings and ensure alignment with contemporary standards.

Data synthesis employed triangulation techniques to reconcile divergent stakeholder views and to validate thematic findings against documented practice patterns. The methodology emphasized transparency: testing modalities were mapped against clinical pathways, and segmentation schemas were cross-checked with stakeholder interviews to ensure practical relevance. Where applicable, sensitivity checks were used to examine the robustness of conclusions under alternative operational scenarios. Finally, findings were peer-reviewed by subject matter experts with clinical and laboratory leadership experience to ensure accuracy and real-world applicability.

Conclusion synthesizing strategic imperatives for responsible adoption, operational rigor, regulatory engagement, and partnership-driven growth in genetic testing

In summary, the genetic testing sector stands at an inflection point where technological maturity, regulatory refinement, and evolving care models intersect to create significant strategic opportunities. Organizations that align product development with validated clinical utility, invest in interoperable data infrastructure, and strengthen supply chain resilience will be best positioned to capture long-term value. At the same time, proactive regulatory engagement and rigorous evidence generation remain essential to expand clinical adoption and ensure sustainable reimbursement pathways.

Looking ahead, success will favor entities that balance innovation with operational rigor, cultivate partnerships across clinical and commercial stakeholders, and design services that integrate seamlessly into existing care workflows. By focusing on these priorities, market participants can accelerate responsible adoption of genetic testing technologies, improve patient outcomes, and build resilient business models that withstand regulatory and macroeconomic headwinds.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Increasing integration of artificial intelligence into genomic data interpretation workflows
  • 5.2. Rising adoption of direct-to-consumer genetic test kits and associated regulatory oversight challenges
  • 5.3. Advancements in CRISPR-based gene editing enabling precise targeting of hereditary disorders
  • 5.4. Expansion of pharmacogenomics for personalized medication selection based on patient genetic profiles
  • 5.5. Emergence of at-home sample collection kits improving access to genetic testing services in rural areas
  • 5.6. Strategic partnerships between biotech firms and healthcare providers to scale genetic screening programs
  • 5.7. Growing demand for comprehensive multiomics approaches integrating genomics proteomics and metabolomics data
  • 5.8. Increasing venture capital investment driving innovation and startup growth in the genetic testing sector
  • 5.9. Evolving regulatory frameworks and data privacy requirements impacting genetic testing commercialization strategies
  • 5.10. Surge in prenatal genetic screening as expectant parents seek early detection of hereditary health risks

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Genetic Testing Market, by Product

  • 8.1. Consumables & Equipment
  • 8.2. Software & Services

9. Genetic Testing Market, by Test Type

  • 9.1. Carrier Testing
  • 9.2. Diagnostic Testing
  • 9.3. New Born Screening
  • 9.4. Pharmacogenomics
  • 9.5. Preimplantation Testing
  • 9.6. Prenatal Testing
  • 9.7. Presymptomatic & Predictive Testing

10. Genetic Testing Market, by Technology

  • 10.1. Cytogenetics
  • 10.2. DNA Sequencing
  • 10.3. Gene Expression Profiling
  • 10.4. Microarrays
  • 10.5. PCR

11. Genetic Testing Market, by Application

  • 11.1. Autoimmune Disorders
  • 11.2. Cancer
  • 11.3. Chronic Diseases
  • 11.4. Genetic Disorders
  • 11.5. Neurodegenerative Diseases

12. Genetic Testing Market, by Distribution Channel

  • 12.1. Offline
  • 12.2. Online

13. Genetic Testing Market, by End-User

  • 13.1. Diagnostic Laboratories
  • 13.2. Home Setting
  • 13.3. Hospitals & Clinics

14. Genetic Testing Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Genetic Testing Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Genetic Testing Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. Competitive Landscape

  • 17.1. Market Share Analysis, 2024
  • 17.2. FPNV Positioning Matrix, 2024
  • 17.3. Competitive Analysis
    • 17.3.1. Abbott Laboratories
    • 17.3.2. Agilent Technologies, Inc.
    • 17.3.3. Becton, Dickinson and Company
    • 17.3.4. Bio-Rad Laboratories, Inc.
    • 17.3.5. Bio-Techne Corporation
    • 17.3.6. Bruker Corporation
    • 17.3.7. Centogene N.V.
    • 17.3.8. Color Health, Inc.
    • 17.3.9. CooperSurgical Inc.
    • 17.3.10. Editas Medicine, Inc.
    • 17.3.11. Eugene Labs Pty Ltd.
    • 17.3.12. Eurofins Scientific SE
    • 17.3.13. F. Hoffmann-La Roche AG
    • 17.3.14. Fulgent Genetics, Inc.
    • 17.3.15. Gene by Gene, Ltd.
    • 17.3.16. GeneDx, LLC
    • 17.3.17. Illumina, Inc.
    • 17.3.18. Invitae Corporation
    • 17.3.19. Laboratory Corporation of America Holdings
    • 17.3.20. Living DNA Ltd.
    • 17.3.21. Macrogen, Inc.
    • 17.3.22. MyHeritage Ltd.
    • 17.3.23. Myriad Genetics, Inc.
    • 17.3.24. Natera, Inc.
    • 17.3.25. Newtopia Inc.
    • 17.3.26. PathogenDx Corporation
    • 17.3.27. PerkinElmer Inc.
    • 17.3.28. Qiagen N.V.
    • 17.3.29. Quest Diagnostics Incorporated
    • 17.3.30. Sanofi S.A.
    • 17.3.31. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2024 VS 2032 (%)
  • FIGURE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. AMERICAS GENETIC TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. EUROPE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. ASEAN GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. GCC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. BRICS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. G7 GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. NATO GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 31. GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 32. GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GENETIC TESTING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL GENETIC TESTING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 163. AMERICAS GENETIC TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 164. AMERICAS GENETIC TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 165. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 166. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 167. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 168. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 169. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 170. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 171. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 172. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 173. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 174. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 175. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 176. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 177. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 178. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 179. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 180. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 181. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 182. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 183. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 184. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 185. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 186. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 187. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 188. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 189. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 190. NORTH AMERICA GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 191. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 192. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 193. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 194. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 195. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 196. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 197. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 198. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 199. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 200. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 201. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 202. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 203. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 204. LATIN AMERICA GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 205. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 206. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 207. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 208. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 209. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 210. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 211. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 212. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 213. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 214. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 215. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 216. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 217. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 218. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 219. EUROPE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. EUROPE GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. EUROPE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 222. EUROPE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 223. EUROPE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. EUROPE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 225. EUROPE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 226. EUROPE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 227. EUROPE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 228. EUROPE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 229. EUROPE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 230. EUROPE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 231. EUROPE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 232. EUROPE GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 233. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 234. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 235. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 236. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 237. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 240. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 241. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 243. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 244. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 245. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 246. MIDDLE EAST GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 247. AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 248. AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 249. AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 250. AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 251. AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 254. AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 255. AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 256. AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 257. AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 259. AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 260. AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 261. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 262. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 263. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 264. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 265. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 266. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 267. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 268. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 269. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 270. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 271. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 272. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 273. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 274. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 275. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 277. ASEAN GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 278. ASEAN GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 279. ASEAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 280. ASEAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 281. ASEAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 282. ASEAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 283. ASEAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 284. ASEAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 285. ASEAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 286. ASEAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 287. ASEAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 288. ASEAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 289. ASEAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 290. ASEAN GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 291. GCC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 292. GCC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 293. GCC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 294. GCC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 295. GCC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. GCC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 297. GCC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 298. GCC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 299. GCC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 300. GCC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 301. GCC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 302. GCC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 303. GCC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 304. GCC GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 305. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 306. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 307. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 308. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 309. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 310. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 311. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 312. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 313. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 315. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 316. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 317. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 318. EUROPEAN UNION GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 319. BRICS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 320. BRICS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 321. BRICS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 322. BRICS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 323. BRICS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 324. BRICS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 325. BRICS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 326. BRICS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 327. BRICS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 328. BRICS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 329. BRICS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 330. BRICS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 331. BRICS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 332. BRICS GENETIC TESTING MARKET SIZE, BY END-USER, 2025-2032 (USD MILLION)
  • TABLE 333. G7 GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 334. G7 GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 335. G7 GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
  • TABLE 336. G7 GENETIC TESTING MARKET SIZE, BY PRODUCT, 2025-2032 (USD MILLION)
  • TABLE 337. G7 GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
  • TABLE 338. G7 GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2032 (USD MILLION)
  • TABLE 339. G7 GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
  • TABLE 340. G7 GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
  • TABLE 341. G7 GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 342. G7 GENETIC TESTING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 343. G7 GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 344. G7 GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2032 (USD MILLION)
  • TABLE 345. G7 GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
  • TABLE 346. G7 GE